Disclosure Statements

GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

  • Personal Benefits (Consultancy-Lecture Fees) refers to fees for lectures, advisory committees or consultancy services either intermittent or regular, from which a GOLD member benefits personally. This includes ongoing attendance at advisory board meetings but would not normally include a situation where an individual is paid for a specific item or for attending or speaking at an occasional meeting.
  • Shares refers to any shares in the pharmaceutical industry, excluding unit trusts, pension plans or mutual funds, and it refers to shares held by a GOLD member or family members (spouse/children). The company is to be listed, not the number of shares.
  • Non-Personal Interests refers to fees or grants paid to a GOLD Committee member (or the Department/Institution on behalf of a GOLD member) and used for research, education, equipment, salaries, etc

For each category, items are included in one of two categories: (1) payment or service is valued in excess of $1,000 (US) but less than $10,000, and (2) payment or service is valued in excess of $10,000. This information disclosed by each member of the GOLD Committees each year is presented in an effort to be as transparent as possible.

Science Committee Disclosure Statement - 2016 update (December 2015) (PDF)

Board of Directors Disclosure Statement (January 2015) (PDF)

GOLD Report Reviewers Disclosure Statement (November 2011) (PDF)